section name header

Information

Author(s): Vimal Venugopal , Vito Carone , Manohara Kenchaiah

Consider hyperosmolar hyperglycaemic state (HHS) in any ill patient with diabetes, especially if volume depletion and drowsiness are prominent.

Hyperosmolar hyperglycaemic state is differentiated from diabetic ketoacidosis (Chapter 83) by:Hyperosmolar hyperglycaemic state is differentiated from diabetic ketoacidosis (Chapter 83) by:
  • Blood glucose >30 mmol/L, but no ketoacidosis (plasma ketones <3 mmol/L, venous bicarbonate >15 mmol/L) and
  • Plasma osmolality >350mOsmol/kg (normal range 285–295mOsmol/kg); this can be measured directly or calculated from the formula: plasma osmolality = [2 (plasma Na)+glucose+urea].

Management

Clinical assessment, investigation and management are as for DKA (Chapter 83), with the differences noted below. Identify and treat any precipitating illness.

Continue insulin unless the total daily requirement falls below 20 units, when an oral hypoglycaemic can be tried. Most patients can subsequently be maintained on oral hypoglycaemic therapy (or even managed by diet alone), although recovery of endogenous insulin production may be delayed. Ask advice from the diabetes team on an appropriate regimen before discharge.

Further Reading

Joint British Diabetes Societies Inpatient Care Group (2012) The management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes. https://www.diabetes.org.uk/Documents/Position%20statements/JBDS-IP-HHS-Adults.pdf